Skip to content

Public FDA record

Z-0899-03: STA-Compact Hemostasis System with Cap piercing capability.

Recall record Z-0899-03 for Diagnostica Stago, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0899-03
Company in FDA record
Diagnostica Stago, Inc.
FDA classification date
May 29, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

With maintenance of the STA line, the cap-piercing feature may involve potential risk of needle puncture injury.

Source facts

Action
The firm sent out letters on March 5, 2003 to their customers alerting them to the problem and providing further guidance on how to prevent the problem. The firm will be sending out to the customers a protective device to attach to the needle assembly as soon as possible
Initiated
2003-03-05
Root cause
Other
Terminated
2003-09-09
Distribution
The product was shipped to 47 hospitals throughout the nation. Other units were shipped to the firm sales representatives.
Recall number
Z-0899-03
Recall status
Terminated
CDRH record ID
26546
FDA classified
2003-05-29
Recall event number
25823

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗